Early Clinical Detection of Pharmacologic Response in Insulin Action in a Non-diabetic Insulin Resistant Population

Conclusions Significant changes in insulin action across multiple insulin sensitive tissues can be detected within 2 weeks of initiation of insulin-sensitizing therapy with pioglitazone in obese non-diabetic insulin resistant subjects. Clinical Trial Registration Number NCT01115712.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research